dihydroxyphenylalanine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 52 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Excerpt | Relevance | Reference |
---|---|---|
"A 48-year-old man with typical Huntington's disease was investigated with computed tomography (CT) and positron emission tomography." | 1.27 | Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography. ( Frackowiak, RS; Leenders, KL; Marsden, CD; Quinn, N, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (94.23) | 18.7374 |
1990's | 2 (3.85) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (1.92) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Michler, E | 1 |
Hoberück, S | 1 |
Martino, F | 1 |
Platzek, I | 1 |
Kotzerke, J | 1 |
SOURKES, TL | 1 |
PIVNICKI, D | 1 |
BROWN, WT | 1 |
WISEMAN-DISTLER, H | 1 |
MURPHY, GF | 1 |
SANKOFF, I | 1 |
SAINTCYR, S | 1 |
Wöller, W | 1 |
Tegeler, J | 1 |
Magalov, ShI | 1 |
Dadali, EL | 1 |
Hume, SP | 1 |
Lammertsma, AA | 1 |
Myers, R | 1 |
Rajeswaran, S | 1 |
Bloomfield, PM | 1 |
Ashworth, S | 1 |
Fricker, RA | 1 |
Torres, EM | 1 |
Watson, I | 1 |
Jones, T | 1 |
Olney, JW | 1 |
Zorumski, CF | 1 |
Stewart, GR | 1 |
Price, MT | 1 |
Wang, GJ | 1 |
Labruyere, J | 1 |
Martin, WR | 2 |
Hayden, MR | 1 |
Leenders, KL | 1 |
Frackowiak, RS | 1 |
Quinn, N | 1 |
Marsden, CD | 1 |
Klawans, HC | 1 |
Paulson, GW | 5 |
Barbeau, A | 4 |
Yuill, GM | 1 |
Tan, BK | 1 |
Leijnse-Ybema, HJ | 2 |
v d Brand, HJ | 1 |
Klawans, HL | 4 |
Goodman, RM | 1 |
Venters, GA | 1 |
Baskin, F | 1 |
Rosenberg, RN | 1 |
Simanyi, M | 1 |
Gerstenbrand, F | 1 |
Gründig, E | 1 |
Schedl, R | 1 |
Weiss, H | 1 |
Shokeir, MH | 1 |
Bruyn, GW | 1 |
von Wolferen, WJ | 1 |
Walker, JE | 1 |
Hoehn, M | 1 |
Sears, E | 1 |
Lewis, J | 1 |
Schenk, G | 1 |
Bird, ED | 1 |
Iversen, LL | 1 |
Cotzias, GC | 1 |
Papavasiliou, PS | 1 |
Gellene, R | 1 |
Bernheimer, H | 2 |
Birkmayer, W | 3 |
Hornykiewicz, O | 2 |
Curzon, G | 1 |
Cederbaum, S | 1 |
Bird, MT | 2 |
Hartmann-von Monakow, K | 1 |
Bond, PA | 1 |
Ringel, SP | 1 |
Fahn, S | 1 |
Goetz, C | 1 |
Westheimer, R | 1 |
Chase, TN | 3 |
Gordon, EK | 1 |
Ng, LK | 2 |
Candelise, L | 1 |
Faglioni, P | 1 |
Spinnler, H | 1 |
Vignolo, LA | 1 |
Constantinidis, J | 1 |
Rondot, P | 1 |
Dumas, RJ | 1 |
Jellinger, K | 1 |
Seitelberger, F | 1 |
Korczyn, AD | 1 |
Podolsky, S | 2 |
Leopold, NA | 2 |
Low, PA | 2 |
Allsop, JL | 2 |
Halmagyi, GM | 1 |
Re', O | 1 |
Matthews, WB | 1 |
Tarsy, D | 1 |
Leopold, N | 1 |
Sax, DS | 1 |
Cramer, H | 1 |
Saïd, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Adenosine A2A Blockade With KW-6002 in Parkinson's Disease[NCT00006337] | Phase 2 | 16 participants | Interventional | 2000-10-31 | Completed | ||
Effect of Antiglutamatergic Treatment in Parkinson's Disease[NCT00013624] | Phase 2 | 20 participants | Interventional | 2001-03-31 | Completed | ||
Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease[NCT00006077] | Phase 2 | 50 participants | Interventional | 2000-08-31 | Completed | ||
Effect of Serotoninergic Treatment in Parkinson's Disease[NCT00009048] | Phase 2 | 30 participants | Interventional | 2001-01-31 | Completed | ||
Levetiracetam Treatment of L-dopa Induced Dyskinesias[NCT00076674] | Phase 2 | 40 participants | Interventional | 2004-01-31 | Completed | ||
AMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's Disease[NCT00004576] | Phase 2 | 20 participants | Interventional | 2000-02-29 | Completed | ||
Prognostic Value of FP-CIT-SPECT in Patients With Parkinson´s Disease[NCT01038310] | 25 participants (Actual) | Observational | 2010-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for dihydroxyphenylalanine and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Cerebral glucose and dopa metabolism in movement disorders.
Topics: Animals; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Humans; Huntington Disease; Park | 1987 |
Positron emission tomography in movement disorders.
Topics: Brain; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Glu | 1985 |
The biochemistry of dyskinesias.
Topics: Acetylcholine; Animals; Catecholamines; Cats; Copper; Dihydroxyphenylalanine; Dogs; Hepatolenticular | 1967 |
Pathophysiology of schizophrenia and the striatum.
Topics: Adult; Amphetamine; Animals; Basal Ganglia; Catalepsy; Caudate Nucleus; Dihydroxyphenylalanine; Dopa | 1972 |
The pharmacology of extrapyramidal movement disorders.
Topics: Basal Ganglia Diseases; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hep | 1973 |
Pathophysiology of drug-induced dyskinesias.
Topics: Brain; Brain Chemistry; Butyrophenones; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Do | 1972 |
2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action.
Topics: Acetylcholine; Blood-Brain Barrier; Brain Chemistry; Carbon Radioisotopes; Child; Choline; Deanol; D | 1974 |
Advances in neurology.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Anticonvulsants; Antihypertens | 1972 |
3 trials available for dihydroxyphenylalanine and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Modification of Parkinsonism--chronic treatment with L-dopa.
Topics: Adult; Aged; Agranulocytosis; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Blo | 1969 |
[10 years of L-DOPA therapy of Parkinson's syndrome].
Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topi | 1971 |
Letter: Treatment of Huntington's chorea.
Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Clinical Trials as Topic; Dia | 1973 |
41 other studies available for dihydroxyphenylalanine and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonan | 2019 |
A CLINICAL AND METABOLIC STUDY OF DOPA (3, 4-DIHYDROXYPHENYLALANINE) AND METHYLDOPA IN HUNTINGTON'S CHOREA.
Topics: Body Fluids; Chorea; Dihydroxyphenylalanine; Drug Therapy; Electroencephalography; Fluids and Secret | 1965 |
[Tardive dyskinesia: clinical picture, prevalence, and pathophysiology].
Topics: Age Factors; Antipsychotic Agents; Diagnosis, Differential; Dihydroxyphenylalanine; Dyskinesia, Drug | 1983 |
[Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)].
Topics: Adolescent; Adult; Aged; Catecholamines; Child; Dihydroxyphenylalanine; Dopamine; Epinephrine; Femal | 1980 |
The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
Topics: Animals; Carbidopa; Carbon Isotopes; Carrier Proteins; Cerebellum; Dihydroxyphenylalanine; Disease M | 1996 |
Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Chick Embryo; Dibenzocyc | 1990 |
Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
Topics: Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenyl | 1986 |
Predictive test for Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease; Movement Disorders; Neurologic Examination; Neur | 1970 |
Parkinsonism and Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease; Parkinson Disease | 1971 |
Levodopa in Huntington's chorea.
Topics: Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Mental Disorders; Middle | 1972 |
Levodopa in the presymptomatic diagnosis of Huntington's chorea.
Topics: Chemoreceptor Cells; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease | 1972 |
Dopa and Huntington's disease.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease | 1973 |
Dopa as an antimetabolite in Huntington's disease.
Topics: Acylation; Adult; Amino Acyl-tRNA Synthetases; Antimetabolites; Basal Ganglia; Caudate Nucleus; Dihy | 1973 |
[Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA
Topics: Adult; Aged; Alanine Transaminase; Asparagine; Aspartic Acid; Child; Dihydroxyphenylalanine; Female; | 1973 |
DOPA as anti-metabolite in Huntington's disease.
Topics: Brain; Catechol Oxidase; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease; Hydroxydopami | 1973 |
Pathogenesis of Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease | 1973 |
Dimethyl aminoethanol in Huntington's chorea.
Topics: Dihydroxyphenylalanine; Ethanol; Humans; Huntington Disease; Physostigmine | 1973 |
Letter: Huntington's chorea and levodopa.
Topics: Carboxy-Lyases; Dihydroxyphenylalanine; Drug Interactions; Drug Therapy, Combination; Haloperidol; H | 1974 |
Letter: Rigidity in Huntington's chorea.
Topics: Basal Ganglia; Brain; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease; Muscle Rigidity; | 1974 |
L-dopa and juvenile Huntington's disease.
Topics: Adolescent; Adult; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Male | 1969 |
[Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
Topics: Adult; Aged; Central Nervous System Diseases; Cerebrospinal Fluid; Dihydroxyphenylalanine; Epilepsy; | 1966 |
Tests for Huntington's chorea.
Topics: 5-Hydroxytryptophan; Dihydroxyphenylalanine; Humans; Huntington Disease | 1971 |
Early onset rigid Huntington's disease.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Dihydroxyphenylalanine; E | 1970 |
[Specific therapy of extrapyramidal-motor syndromes].
Topics: Analgesics; Athetosis; Chorea; Datura stramonium; Dihydroxyphenylalanine; Dystonia Musculorum Deform | 1969 |
The determination of 4-hydroxy-3-methoxyphenylethylene glycol in urine and CSF using gas chromatography.
Topics: Acetates; Adult; Catechols; Chromatography, Gas; Chromatography, Ion Exchange; Dihydroxyphenylalanin | 1972 |
Use of L-dopa in the detection of presymptomatic Huntington's chorea.
Topics: Adolescent; Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; False Posit | 1972 |
L-dopa effect in Huntington's chorea.
Topics: Dihydroxyphenylalanine; Humans; Huntington Disease; Parkinson Disease | 1972 |
Presymptomatic detection of Huntington's chorea.
Topics: Adolescent; Adult; Dihydroxyphenylalanine; Eugenics; Humans; Huntington Disease | 1972 |
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Carbon Radioisotopes; Cerebrospinal Fluid; Child; | 1973 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus | 1972 |
[Dopamine and abnormal movements].
Topics: Benserazide; Body Weight; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Electro | 1972 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Topics: Aged; Autopsy; Basal Ganglia; Benzoates; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; D | 1973 |
Biogenic amines in the hypothalamus: effect of L-DOPA on human growth hormone levels in patients with Huntington's chorea.
Topics: Dihydroxyphenylalanine; Growth Hormone; Humans; Huntington Disease; Male; Time Factors | 1973 |
Huntington's chorea: the rigid form (Westphal variant) treated with levodopa.
Topics: Adult; Dihydroxyphenylalanine; Female; Hallucinations; Humans; Huntington Disease | 1974 |
Huntington's chorea--the rigid form (Westphal variant) treated with l-DOPA: a case report.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Huntington Disease | 1973 |
Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
Topics: Adult; Aged; Depression, Chemical; Dihydroxyphenylalanine; Glucose Tolerance Test; Growth Hormone; H | 1974 |
The rigid form of Huntington's chorea.
Topics: Adult; Age Factors; Amantadine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Movement | 1971 |
Physostigmine in choreiform movement disorders.
Topics: Acetylcholine; Adult; Aged; Art; Athetosis; Chorea; Corpus Striatum; Dihydroxyphenylalanine; Female; | 1974 |
Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.
Topics: Adolescent; Adult; Aged; Cerebellar Diseases; Child; Cyclic AMP; Dihydroxyphenylalanine; Female; Hom | 1973 |
Serotonergic-dopaminergic interactions and extrapyramidal function.
Topics: Biogenic Amines; Brain; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Humans; Huntington | 1974 |
[Dystonias].
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Extra | 1972 |